DaVita Inc. (NYSE:DVA) Shares Purchased by Intech Investment Management LLC

Intech Investment Management LLC increased its holdings in shares of DaVita Inc. (NYSE:DVA) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,265 shares of the company’s stock after acquiring an additional 328 shares during the quarter. Intech Investment Management LLC’s holdings in DaVita were worth $4,077,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of DVA. Atria Investments Inc increased its stake in shares of DaVita by 12.3% in the third quarter. Atria Investments Inc now owns 2,897 shares of the company’s stock valued at $475,000 after purchasing an additional 317 shares during the period. Empowered Funds LLC increased its stake in shares of DaVita by 25.6% in the third quarter. Empowered Funds LLC now owns 5,824 shares of the company’s stock valued at $955,000 after purchasing an additional 1,187 shares during the period. Thrivent Financial for Lutherans increased its stake in shares of DaVita by 49.4% in the third quarter. Thrivent Financial for Lutherans now owns 8,131 shares of the company’s stock valued at $1,333,000 after purchasing an additional 2,688 shares during the period. Quest Partners LLC acquired a new stake in shares of DaVita in the third quarter valued at approximately $669,000. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of DaVita in the third quarter valued at approximately $923,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Trading Up 0.0 %

Shares of NYSE:DVA opened at $149.27 on Wednesday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The stock has a market capitalization of $11.94 billion, a price-to-earnings ratio of 13.90, a PEG ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60. The company has a 50 day moving average price of $158.80 and a 200 day moving average price of $157.61.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, research analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on DVA. Barclays raised their price target on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a report on Friday, February 21st. Finally, Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, DaVita has an average rating of “Hold” and a consensus price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.